Answers are grounded in this paper and cite their sources.
Background : Bilirubin is an essential biomarker for detecting various liver, kidney, and biliary tract disorders. Hence, precise quantification of this prognostic indicator holds significant value. Results : In this work, we have developed an ensemble‐based sensor (i.e., A3‐HSA), which successfully detects bilirubin in both buffer and urine samples. Two potential ensembles were initially tested: the A3‐HSA and A4‐HSA. While the former showed a turn‐off signal, the latter's signal remained largely unperturbed. Consequently, A3‐HSA conjugate was chosen for bilirubin sensing based on its distinct signal, and the limit of detection was found to be 2.77 µM. Molecular docking, MD simulations, and MMGBSA calculations were also performed to develop an understanding of the interactions between the ligands A3/A4/bilirubin and HSA. Calculations showed the strongest binding between bilirubin and HSA, thus facilitating the replacement of A3 from the IB site of HSA. The developed method was also validated using human urine samples and showed efficacy in measuring bilirubin levels at lower concentrations. Significance : The simplicity of the devised ensemble and its capability to work in urine allow for the easy detection of bilirubin, which is generally implicated in multiple ailments.
No takes yet. Share an insight, caveat, or question.
Bandyopadhyay et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: